Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development
Micaela Gliozzi,Miriam Scicchitano,Francesca Bosco,Vincenzo Musolino,Cristina Carresi,Federica Scarano,Jessica Maiuolo,Saverio Nucera,Alessia Maretta,Sara Paone,Rocco Mollace,Stefano Ruga,Maria Caterina Zito,Roberta Macrì,Francesca Oppedisano,Ernesto Palma,Daniela Salvemini,Carolina Muscoli,Vincenzo Mollace
DOI: https://doi.org/10.3390/ijms20133294
IF: 5.6
2019-07-04
International Journal of Molecular Sciences
Abstract:The maintenance of physiological levels of nitric oxide (NO) produced by eNOS represents a key element for vascular endothelial homeostasis. On the other hand, NO overproduction, due to the activation of iNOS under different stress conditions, leads to endothelial dysfunction and, in the late stages, to the development of atherosclerosis. Oxidized LDLs (oxLDLs) represent the major candidates to trigger biomolecular processes accompanying endothelial dysfunction and vascular inflammation leading to atherosclerosis, though the pathophysiological mechanism still remains to be elucidated. Here, we summarize recent evidence suggesting that oxLDLs produce significant impairment in the modulation of the eNOS/iNOS machinery, downregulating eNOS via the HMGB1-TLR4-Caveolin-1 pathway. On the other hand, increased oxLDLs lead to sustained activation of the scavenger receptor LOX-1 and, subsequently, to NFkB activation, which, in turn, increases iNOS, leading to EC oxidative stress. Finally, these events are associated with reduced protective autophagic response and accelerated apoptotic EC death, which activates atherosclerotic development. Taken together, this information sheds new light on the pathophysiological mechanisms of oxLDL-related impairment of EC functionality and opens new perspectives in atherothrombosis prevention.